Our investigation of the correlation between serum sPD‐1/sPD‐L1 and clinical indicators revealed that dynamic monitoring of serum sPD‐1/sPD‐L1 levels in AP patients may reflect systemic immunologic functions in AP patients. The gene discussed is SPDL1; the disease is alkaline phosphatase measurement.